Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> Tanzania Deploys ‘HeroRats’ to Improve Tuberculosis Diagnosis 06/01/2023 Kizito Makoye For months, Sharifa Shomale suffered in silence from tuberculosis, not knowing what was wrong with her. Doctors suspected a viral infection. Then an unlikely hero made a life-saving discovery: a mischievous rat named Hamisi. DAR ES SALAAM, Tanzania—Every evening, as the call to prayer from the mosque echoes in the twilight from Manzese—a tangled Dar […] Continue reading -> In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to […] Continue reading -> Shorter Treatment Regimen for Drug-Resistant TB is More Effective 08/11/2022 Kerry Cullinan Two shorter treatment regimens for multi-drug resistant (MDR) tuberculosis have proven to be safe and more effective than the current treatment, the Union World Conference on Lung Health heard on Tuesday. Results from Stage 2 of the STREAM clinical trial, published in The Lancet on the same day, show that a fully-oral nine-month bedaquiline-based regimen […] Continue reading -> Global Fund Still Short of $18 Billion Target for Fighting HIV, TB and Malaria – But UK and Italy Have Yet to Announce Pledges 22/09/2022 Kerry Cullinan The Global Fund raised $14.25 billion at its seventh replenishment conference in New York on Wednesday – still some way short of its $18 billion target for the next three years, although the United Kingdom and Italy had yet to make their commitments at the end of a day of public pledges. US President Joe […] Continue reading -> Global Fund Blitz Aims to Offset Shortfall 20/09/2022 Kerry Cullinan The Global Fund goes into its pledging conference on Wednesday substantially short of its $18 billion minimum target to fight HIV/AIDS, tuberculosis and malaria over the next five years. Hosted by US President Joe Biden on the sidelines of the United Nations General Assembly (UNGA), the seventh replenishment conference is the culmination of a months-long […] Continue reading -> Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tanzania Deploys ‘HeroRats’ to Improve Tuberculosis Diagnosis 06/01/2023 Kizito Makoye For months, Sharifa Shomale suffered in silence from tuberculosis, not knowing what was wrong with her. Doctors suspected a viral infection. Then an unlikely hero made a life-saving discovery: a mischievous rat named Hamisi. DAR ES SALAAM, Tanzania—Every evening, as the call to prayer from the mosque echoes in the twilight from Manzese—a tangled Dar […] Continue reading -> In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to […] Continue reading -> Shorter Treatment Regimen for Drug-Resistant TB is More Effective 08/11/2022 Kerry Cullinan Two shorter treatment regimens for multi-drug resistant (MDR) tuberculosis have proven to be safe and more effective than the current treatment, the Union World Conference on Lung Health heard on Tuesday. Results from Stage 2 of the STREAM clinical trial, published in The Lancet on the same day, show that a fully-oral nine-month bedaquiline-based regimen […] Continue reading -> Global Fund Still Short of $18 Billion Target for Fighting HIV, TB and Malaria – But UK and Italy Have Yet to Announce Pledges 22/09/2022 Kerry Cullinan The Global Fund raised $14.25 billion at its seventh replenishment conference in New York on Wednesday – still some way short of its $18 billion target for the next three years, although the United Kingdom and Italy had yet to make their commitments at the end of a day of public pledges. US President Joe […] Continue reading -> Global Fund Blitz Aims to Offset Shortfall 20/09/2022 Kerry Cullinan The Global Fund goes into its pledging conference on Wednesday substantially short of its $18 billion minimum target to fight HIV/AIDS, tuberculosis and malaria over the next five years. Hosted by US President Joe Biden on the sidelines of the United Nations General Assembly (UNGA), the seventh replenishment conference is the culmination of a months-long […] Continue reading -> Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to […] Continue reading -> Shorter Treatment Regimen for Drug-Resistant TB is More Effective 08/11/2022 Kerry Cullinan Two shorter treatment regimens for multi-drug resistant (MDR) tuberculosis have proven to be safe and more effective than the current treatment, the Union World Conference on Lung Health heard on Tuesday. Results from Stage 2 of the STREAM clinical trial, published in The Lancet on the same day, show that a fully-oral nine-month bedaquiline-based regimen […] Continue reading -> Global Fund Still Short of $18 Billion Target for Fighting HIV, TB and Malaria – But UK and Italy Have Yet to Announce Pledges 22/09/2022 Kerry Cullinan The Global Fund raised $14.25 billion at its seventh replenishment conference in New York on Wednesday – still some way short of its $18 billion target for the next three years, although the United Kingdom and Italy had yet to make their commitments at the end of a day of public pledges. US President Joe […] Continue reading -> Global Fund Blitz Aims to Offset Shortfall 20/09/2022 Kerry Cullinan The Global Fund goes into its pledging conference on Wednesday substantially short of its $18 billion minimum target to fight HIV/AIDS, tuberculosis and malaria over the next five years. Hosted by US President Joe Biden on the sidelines of the United Nations General Assembly (UNGA), the seventh replenishment conference is the culmination of a months-long […] Continue reading -> Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Shorter Treatment Regimen for Drug-Resistant TB is More Effective 08/11/2022 Kerry Cullinan Two shorter treatment regimens for multi-drug resistant (MDR) tuberculosis have proven to be safe and more effective than the current treatment, the Union World Conference on Lung Health heard on Tuesday. Results from Stage 2 of the STREAM clinical trial, published in The Lancet on the same day, show that a fully-oral nine-month bedaquiline-based regimen […] Continue reading -> Global Fund Still Short of $18 Billion Target for Fighting HIV, TB and Malaria – But UK and Italy Have Yet to Announce Pledges 22/09/2022 Kerry Cullinan The Global Fund raised $14.25 billion at its seventh replenishment conference in New York on Wednesday – still some way short of its $18 billion target for the next three years, although the United Kingdom and Italy had yet to make their commitments at the end of a day of public pledges. US President Joe […] Continue reading -> Global Fund Blitz Aims to Offset Shortfall 20/09/2022 Kerry Cullinan The Global Fund goes into its pledging conference on Wednesday substantially short of its $18 billion minimum target to fight HIV/AIDS, tuberculosis and malaria over the next five years. Hosted by US President Joe Biden on the sidelines of the United Nations General Assembly (UNGA), the seventh replenishment conference is the culmination of a months-long […] Continue reading -> Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Still Short of $18 Billion Target for Fighting HIV, TB and Malaria – But UK and Italy Have Yet to Announce Pledges 22/09/2022 Kerry Cullinan The Global Fund raised $14.25 billion at its seventh replenishment conference in New York on Wednesday – still some way short of its $18 billion target for the next three years, although the United Kingdom and Italy had yet to make their commitments at the end of a day of public pledges. US President Joe […] Continue reading -> Global Fund Blitz Aims to Offset Shortfall 20/09/2022 Kerry Cullinan The Global Fund goes into its pledging conference on Wednesday substantially short of its $18 billion minimum target to fight HIV/AIDS, tuberculosis and malaria over the next five years. Hosted by US President Joe Biden on the sidelines of the United Nations General Assembly (UNGA), the seventh replenishment conference is the culmination of a months-long […] Continue reading -> Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Blitz Aims to Offset Shortfall 20/09/2022 Kerry Cullinan The Global Fund goes into its pledging conference on Wednesday substantially short of its $18 billion minimum target to fight HIV/AIDS, tuberculosis and malaria over the next five years. Hosted by US President Joe Biden on the sidelines of the United Nations General Assembly (UNGA), the seventh replenishment conference is the culmination of a months-long […] Continue reading -> Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Posts navigation Older postsNewer posts